{"id":"conversion-schedule-week-1","safety":{"commonSideEffects":[{"rate":"4-10%","effect":"Dizziness"},{"rate":"3-6%","effect":"Headache"},{"rate":"2-5%","effect":"Fatigue"},{"rate":"2-5%","effect":"Cough"},{"rate":"2-5%","effect":"Diarrhea"}]},"_chembl":{"chemblId":"CHEMBL409372","moleculeType":"Protein","molecularWeight":"2409.89"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Losartan works by selectively blocking the angiotensin II type 1 (AT1) receptor, which is a key component of the renin-angiotensin-aldosterone system (RAAS). This blockade leads to vasodilation and a decrease in blood pressure.","oneSentence":"This drug is used to treat hypertension by blocking the action of angiotensin II at its receptor.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:31:12.589Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"}]},"trialDetails":[{"nctId":"NCT06949111","phase":"PHASE2","title":"Radiotherapy + Systemic Therapy as Conversion Therapy for pMMR/MSS T4M0 Colon Cancer（Neo-Color）","status":"RECRUITING","sponsor":"Hebei Medical University Fourth Hospital","startDate":"2025-05-15","conditions":"Colon Cancer","enrollment":128},{"nctId":"NCT07010393","phase":"PHASE4","title":"Genotype-Driven Neoadjuvant Therapy for Locally Advanced Thyroid Cancer: A Real-World Cohort Study","status":"NOT_YET_RECRUITING","sponsor":"Fujian Medical University","startDate":"2025-07-01","conditions":"Thyroid Neoplasms","enrollment":335},{"nctId":"NCT06993025","phase":"PHASE2","title":"Ivonescimab in Combination With Liposomal Irinotecan and 5-FU/LV in Potentially Resectable Biliary Tract Malignancies","status":"NOT_YET_RECRUITING","sponsor":"Tianjin Medical University Cancer Institute and Hospital","startDate":"2025-05-25","conditions":"Biliary Tract Cancer","enrollment":30},{"nctId":"NCT03670953","phase":"PHASE3","title":"A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Participants With Motor Fluctuations","status":"COMPLETED","sponsor":"Impax Laboratories, LLC","startDate":"2018-11-06","conditions":"Parkinson's Disease (Disorder)","enrollment":630},{"nctId":"NCT05394415","phase":"PHASE1, PHASE2","title":"Chemoradiation Plus Tislelizumab for Conversion Therapy of Locally Nonresectable ESCC","status":"UNKNOWN","sponsor":"Jiangsu Cancer Institute & Hospital","startDate":"2022-05-01","conditions":"Esophageal Squamous Cell Carcinoma, Tislelizumab, Chemoradiation","enrollment":30},{"nctId":"NCT00551603","phase":"PHASE4","title":"Anaemia Correction in Haemodialyzed Patients - Comparative Analysis of Two Erythropoietin Stimulating Agents Schedules","status":"WITHDRAWN","sponsor":"Anemia Working Group Romania","startDate":"2006-07","conditions":"Bio-Equivalency of 2 Treatment Schedules in HD Patients","enrollment":""},{"nctId":"NCT01932502","phase":"PHASE4","title":"Evaluation of Onfi Conversion Therapy Replacing Clonazepam in Patients With Medically Refractory Epilepsy","status":"UNKNOWN","sponsor":"St. Joseph's Hospital and Medical Center, Phoenix","startDate":"2013-02","conditions":"Refractory Epilepsy","enrollment":21}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["clobazam (Onfi)"],"phase":"marketed","status":"active","brandName":"Conversion schedule - Week 1","genericName":"Conversion schedule - Week 1","companyName":"St. Joseph's Hospital and Medical Center, Phoenix","companyId":"st-joseph-s-hospital-and-medical-center-phoenix","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This drug is used to treat hypertension by blocking the action of angiotensin II at its receptor. Used for Hypertension.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}